再生元制药公司跌2.09% 股价跌破700美元大关

市场透视12-19

北京时间2024年12月19日22时43分，再生元制药公司（REGN.us）股票出现波动，股价大幅下挫2.09%。截至发稿，该股报699.67美元/股，成交量6.0658万股，换手率0.06%，振幅1.67%。最近的财报数据显示，该股实现营业收入37.21亿美元，净利润13.41亿美元，每股收益12.40美元，毛利31.08亿美元，市盈率17.37倍。机构评级方面，在所有28家参与评级的机构中，...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2492172953?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-12-19 22:43","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2492172953","market":"us","top_or_hot":-1,"title":"再生元制药公司跌2.09% 股价跌破700美元大关","media":"市场透视","content":"<div>\n<p>北京时间2024年12月19日22时43分，再生元制药公司（REGN.us）股票出现波动，股价大幅下挫2.09%。截至发稿，该股报699.67美元/股，成交量6.0658万股，换手率0.06%，振幅1.67%。最近的财报数据显示，该股实现营业收入37.21亿美元，净利润13.41亿美元，每股收益12.40美元，毛利31.08亿美元，市盈率17.37倍。机构评级方面，在所有28家参与评级的机构中，...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121922431195ea7afe&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>再生元制药公司跌2.09% 股价跌破700美元大关</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n再生元制药公司跌2.09% 股价跌破700美元大关\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-19 22:43 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121922431195ea7afe&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年12月19日22时43分，再生元制药公司（REGN.us）股票出现波动，股价大幅下挫2.09%。截至发稿，该股报699.67美元/股，成交量6.0658万股，换手率0.06%，振幅1.67%。最近的财报数据显示，该股实现营业收入37.21亿美元，净利润13.41亿美元，每股收益12.40美元，毛利31.08亿美元，市盈率17.37倍。机构评级方面，在所有28家参与评级的机构中，...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121922431195ea7afe&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU2468319806.SGD","symbol_name":"MANULIFE GF HEALTHCARE \"AA\" (SGDHDG) ACC","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121922431195ea7afe&s=b","article_id":"2492172953","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121922431195ea7afe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2492172953","pubTimestamp":1734619391,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年12月19日22时43分，再生元制药公司股票出现波动，股价大幅下挫2.09%。截至发稿，该股报699.67美元/股，成交量6.0658万股，换手率0.06%，振幅1.67%。最近的财报数据显示，该股实现营业收入37.21亿美元，净利润13.41亿美元，每股收益12.40美元，毛利31.08亿美元，市盈率17.37倍。再生元制药公司股票所在的生物技术行业中，整体跌幅为2.75%。再生元制药公司公司简介：Regeneron Pharmaceuticals 发现、开发和商业化用于治疗眼部疾病、心血管疾病、癌症和炎症的产品。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LU2468319806.SGD":"MANULIFE GF HEALTHCARE \"AA\" (SGDHDG) ACC","REGN":"再生元制药公司","LU0889565916.HKD":"FRANKLIN BIOTECHNOLOGY DISCOVERY \"A\" (HKD) ACC","LU1917777945.USD":"安联专题基金Cl AT Acc","LU1974910355.USD":"Allianz Thematica Cl AMg DIS USD","LU2089984988.USD":"MANULIFE GF HEALTHCARE \"AA\" (USD) ACC","BK4585":"ETF&股票定投概念","LU0823416689.USD":"BNP PARIBAS HEALTH CARE INNOVATORS \"C\" (USD) ACC","BK4139":"生物科技","LU0053666078.USD":"摩根大通基金-美国股票A（离岸）美元","LU2106854487.HKD":"ALLIANZ THEMATICA \"AMG\" (HKD) INC","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","LU0320765992.SGD":"FTIF - Franklin Biotechnology Discovery A Acc SGD","LU2362540622.SGD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (SGDHDG) ACC","LU2023250504.SGD":"Allianz Thematica Cl AMg DIS H2-SGD","BK4588":"碎股","LU0109394709.USD":"富兰克林生物科技新领域基金A (acc)","LU0058720904.USD":"联博国际健康护理基金A","LU0882574055.USD":"富达全球健康医疗A ACC","LU0114720955.EUR":"SUSTAINABLE GLOBAL HEALTH CARE \"A\" INC","LU2362541513.USD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (USD) ACC","LU2362541273.HKD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (HKD) ACC"},"translate_title":"Regeneron Pharmaceuticals falls 2.09%, shares fall below the $700 mark","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"REGN":1},"content_text":"北京时间2024年12月19日22时43分，再生元制药公司（REGN.us）股票出现波动，股价大幅下挫2.09%。截至发稿，该股报699.67美元/股，成交量6.0658万股，换手率0.06%，振幅1.67%。最近的财报数据显示，该股实现营业收入37.21亿美元，净利润13.41亿美元，每股收益12.40美元，毛利31.08亿美元，市盈率17.37倍。机构评级方面，在所有28家参与评级的机构中，68%的券商给予买入建议，29%的券商给予持有建议，3%的券商给予卖出建议。再生元制药公司股票所在的生物技术行业中，整体跌幅为2.75%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026(To Pur Com)、Abpro Holdings Inc C/Wts 12/11/2029 (To Pur Com)、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 (To Pur Com)涨幅较大，Phio Pharmaceuticals Corp.、Psyence Biomedical Ltd.、Elevai Labs, Inc.较为活跃，换手率分别为421.38%、362.93%、344.25%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026(To Pur Com)、Sab Biotherapeutics Inc C/Wts 22/10/2026 (To Pur Com)、Mesoblast Ltd，振幅分别为92.86%、41.50%、39.17%。再生元制药公司公司简介：Regeneron Pharmaceuticals 发现、开发和商业化用于治疗眼部疾病、心血管疾病、癌症和炎症的产品。该公司有多种已上市产品，包括低剂量 Eylea 和 Eylea HD、已获批用于治疗湿性年龄相关性黄斑变性和其他眼部疾病、免疫学领域的达必妥；用于降低低密度脂蛋白胆固醇的波立达；肿瘤学领域的 Libtayo；以及类风湿性关节炎领域的 Kevzara。Regeneron 还独立地与赛诺菲以及其他合作伙伴合作开发单克隆和双特异性抗体，并建立了早期合作伙伴关系，为产品线带来新技术，包括 RNAi（Alnylam）和基于 Crispr 的基因编辑（Intellia）。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2492172953"}